Teva Wraps Up $703M Sale of Global Women’s Health Biz to CVC Capital Post author:Sam Post published:January 31, 2018 Post category:BioPharma The portfolio includes Ovaleap, Zoely, Seasonique, Colpotrophine, Actonel and additional products. Source: BioSpace You Might Also Like Kirin Cashes Out of Amgen Drug Joint Venture for $780M October 30, 2017 AbbVie Declares Quarterly Dividend February 19, 2017 Arena To Provide Corporate Update And Release Fourth Quarter And Full-Year 2016 Financial Results On Tuesday, March 14, 2017 March 6, 2017
Arena To Provide Corporate Update And Release Fourth Quarter And Full-Year 2016 Financial Results On Tuesday, March 14, 2017 March 6, 2017